Are you "Tilting at windmills" or undertaking a valid clinical trial?

Yonsei Medical Journal

Volumn 52, Issue 5, 2011, Pages 701-716

  Steeves, John D ^a   Zariffa, Jose ^a   Kramer, John L K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Guidelines; Human; Neurology; Protocol; Research; Translation

Indexed keywords

PACLITAXEL; TGN 1412; THALIDOMIDE;

BIRTH DEFECT; CLINICAL RESEARCH; CLINICAL TRIAL; CLINICAL TRIAL (TOPIC); EXPERIMENTAL STUDY; FETUS DEATH; HUMAN; INFLAMMATION; MORNING SICKNESS; MULTIPLE ORGAN FAILURE; NONHUMAN; PAIN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); REVIEW; SIDE EFFECT; STUDY DESIGN; TERATOGENICITY; TREATMENT OUTCOME;

ANIMALS; CLINICAL PROTOCOLS; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PREGNANCY; TRANSLATIONAL MEDICAL RESEARCH;

EID: 79961004319     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2011.52.5.701     Document Type: Review

References (20)

1. Bown SR. Scurvy: How a Surgeon, a Mariner, and a Gentleman Solved the Greatest Medical Mystery of the Age of Sail. New York: Thomas Dunne Books (St. Martin's Press); 2004.
2. Smith GC, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ 2003;327:1459-61.
3. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336: 924-6.
4. Steeves JD. Considerations for the Translation of Pre-Clinical Discoveries and the Conduct of Valid Spinal Cord injury Clinical Trials. In: Lin VW, editor. Spinal Cord Medicine. 2nd ed. New York: Demos; 2010. p.930-8.
5. Kwon BK, Okon EB, Tsai E, Beattie MS, Bresnahan JC, Magnuson DK, Reier PJ, et al. A Grading System To Evaluate Objectively the Strength of Pre-Clinical Data of Acute Neuroprotective Therapies for Clinical Translation in Spinal Cord Injury. J Neurotrauma 2010 Oct 18. [Epub ahead of print]
6. Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, Hill CE, Sparling JS, Plemel JR, et al. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrama 2010; doi:10.1089/neu.2009.1177.
7. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-76.
8. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-72.
9. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-20.
10. Blight A, Curt A, Ditunno JF, Dobkin B, Ellaway P, Fawcett J, et al. Position statement on the sale of unproven cellular therapies for spinal cord injury: the international campaign for cures of spinal cord injury paralysis. Spinal Cord 2009;47:713-4.
11. Fawcett JW, Curt A, Steeves JD, Coleman WP, Tuszynski MH, Lammertse D, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 2007;45:190-205.
12. Steeves JD, Lammertse D, Curt A, Fawcett JW, Tuszynski MH, Ditunno JF, et al. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord 2007;45:206-21.
13. Tuszynski MH, Steeves JD, Fawcett JW, Lammertse D, Kalichman M, Rask C, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics. Spinal Cord 2007;45: 222-31.
14. Lammertse D, Tuszynski MH, Steeves JD, Curt A, Fawcett JW, Rask C, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design. Spinal Cord 2007;45:232-42.
15. Steeves JD, Kramer JK, Fawcett JW, Cragg J, Lammertse DP, Blight AR, et al. Extent of spontaneous motor recovery after traumatic cervical sensorimotor complete spinal cord injury. Spinal Cord 2011;49:257-65.
16. Zariffa J, Kramer JL, Fawcett JW, Lammertse DP, Blight AR, Guest J, et al. Characterization of neurological recovery following traumatic sensorimotor complete thoracic spinal cord injury. Spinal Cord 2011;49:463-71.
17. Illes J, Reimer JC, Kwon BK. Stem Cell Clinical Trials for Spinal Cord Injury: Readiness, Reluctance, Redefinition. Stem Cell Rev 2011.
18. Donovan WH. Ethics, health care and spinal cord injury: research, practice and finance. Spinal Cord 2011;49:162-74.
19. Ziebland S, Featherstone K, Snowdon C, Barker K, Frost H, Fairbank J. Does it matter if clinicians recruiting for a trial don't understand what the trial is really about? Qualitative study of surgeons' experiences of participation in a pragmatic multicentre RCT. Trials 2007;8:4.
20. Gatchel RJ, Lurie JD, Mayer TG. Minimal clinically important difference. Spine (Phila Pa 1976) 2010;35:1739-43.